131 related articles for article (PubMed ID: 37714256)
21. Germline Lysine-Specific Demethylase 1 (
Wei X; Calvo-Vidal MN; Chen S; Wu G; Revuelta MV; Sun J; Zhang J; Walsh MF; Nichols KE; Joseph V; Snyder C; Vachon CM; McKay JD; Wang SP; Jayabalan DS; Jacobs LM; Becirovic D; Waller RG; Artomov M; Viale A; Patel J; Phillip J; Chen-Kiang S; Curtin K; Salama M; Atanackovic D; Niesvizky R; Landgren O; Slager SL; Godley LA; Churpek J; Garber JE; Anderson KC; Daly MJ; Roeder RG; Dumontet C; Lynch HT; Mullighan CG; Camp NJ; Offit K; Klein RJ; Yu H; Cerchietti L; Lipkin SM
Cancer Res; 2018 May; 78(10):2747-2759. PubMed ID: 29559475
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
Wu X; Subramaniam M; Grygo SB; Sun Z; Negron V; Lingle WL; Goetz MP; Ingle JN; Spelsberg TC; Hawse JR
Breast Cancer Res; 2011 Mar; 13(2):R27. PubMed ID: 21392396
[TBL] [Abstract][Full Text] [Related]
23. Capsaicin: A "hot" KDM1A/LSD1 inhibitor from peppers.
Jia G; Cang S; Ma P; Song Z
Bioorg Chem; 2020 Oct; 103():104161. PubMed ID: 32889380
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
Zhao L; Huang S; Mei S; Yang Z; Xu L; Zhou N; Yang Q; Shen Q; Wang W; Le X; Lau WB; Lau B; Wang X; Yi T; Zhao X; Wei Y; Warner M; Gustafsson JÅ; Zhou S
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3673-E3681. PubMed ID: 29592953
[TBL] [Abstract][Full Text] [Related]
25. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
[TBL] [Abstract][Full Text] [Related]
26. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.
Kashyap V; Ahmad S; Nilsson EM; Helczynski L; Kenna S; Persson JL; Gudas LJ; Mongan NP
Mol Oncol; 2013 Jun; 7(3):555-66. PubMed ID: 23384557
[TBL] [Abstract][Full Text] [Related]
27. ERα and ERβ Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions.
Song D; He H; Indukuri R; Huang Z; Stepanauskaite L; Sinha I; Haldosén LA; Zhao C; Williams C
Front Endocrinol (Lausanne); 2022; 13():930227. PubMed ID: 35872983
[TBL] [Abstract][Full Text] [Related]
28. CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability.
Mircetic J; Camgöz A; Abohawya M; Ding L; Dietzel J; Tobar SG; Paszkowski-Rogacz M; Seidlitz T; Schmäche T; Mehnert MC; Sidorova O; Weitz J; Buchholz F; Stange DE
Small Methods; 2023 Jun; 7(6):e2201605. PubMed ID: 36908010
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells.
Yap OW; Bhat G; Liu L; Tollefsbol TO
Anticancer Res; 2009 Jan; 29(1):139-44. PubMed ID: 19331143
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.
Galea GL; Meakin LB; Sugiyama T; Zebda N; Sunters A; Taipaleenmaki H; Stein GS; van Wijnen AJ; Lanyon LE; Price JS
J Biol Chem; 2013 Mar; 288(13):9035-48. PubMed ID: 23362266
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells.
Treeck O; Diepolder E; Skrzypczak M; Schüler-Toprak S; Ortmann O
BMC Cancer; 2019 Jul; 19(1):745. PubMed ID: 31357971
[TBL] [Abstract][Full Text] [Related]
32. Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma.
Huang M; Chen C; Geng J; Han D; Wang T; Xie T; Wang L; Wang Y; Wang C; Lei Z; Chu X
Cancer Lett; 2017 Jul; 398():12-21. PubMed ID: 28377178
[TBL] [Abstract][Full Text] [Related]
33. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.
Wang Y; Cao K
J Immunol Res; 2021; 2021():9965099. PubMed ID: 34307695
[TBL] [Abstract][Full Text] [Related]
34. Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer.
Bossard C; Busson M; Vindrieux D; Gaudin F; Machelon V; Brigitte M; Jacquard C; Pillon A; Balaguer P; Balabanian K; Lazennec G
PLoS One; 2012; 7(9):e44787. PubMed ID: 22970307
[TBL] [Abstract][Full Text] [Related]
35. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
37. KDM1A microenvironment, its oncogenic potential, and therapeutic significance.
Ismail T; Lee HK; Kim C; Kwon T; Park TJ; Lee HS
Epigenetics Chromatin; 2018 Jun; 11(1):33. PubMed ID: 29921310
[TBL] [Abstract][Full Text] [Related]
38. PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer.
Li J; Zhuang Q; Lan X; Zeng G; Jiang X; Huang Z
IUBMB Life; 2013 Dec; 65(12):1017-25. PubMed ID: 24376209
[TBL] [Abstract][Full Text] [Related]
39. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells.
Chu S; Nishi Y; Yanase T; Nawata H; Fuller PJ
Mol Endocrinol; 2004 Aug; 18(8):1919-28. PubMed ID: 15155785
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells.
Edvardsson K; Ström A; Jonsson P; Gustafsson JÅ; Williams C
Mol Endocrinol; 2011 Jun; 25(6):969-79. PubMed ID: 21493669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
